Comment on: “Cost Effectiveness of Tiotropium in Patients with Asthma Poorly Controlled on Inhaled Glucocorticosteroids and Long-Acting β-Agonists”
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1896
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Comment on: “Cost Effectiveness of Tiotropium in Patients with Asthma Poorly Controlled on Inhaled Glucocorticosteroids and Long-Acting β-Agonists” ; volume:14 ; number:1 ; day:30 ; month:12 ; year:2015 ; pages:117-118 ; date:2.2016
Applied health economics and health policy ; 14, Heft 1 (30.12.2015), 117-118, 2.2016
- Creator
-
Samuelsen, Carl
Bateman, Eric D.
Pavord, Ian
Lloyd, Adam
Baldwin, Mike
Esser, Dirk
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40258-015-0215-0
- URN
-
urn:nbn:de:101:1-2019070518592477306103
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Samuelsen, Carl
- Bateman, Eric D.
- Pavord, Ian
- Lloyd, Adam
- Baldwin, Mike
- Esser, Dirk
- SpringerLink (Online service)
Other Objects (12)
Add-on Therapy for Symptomatic Asthma despite Long-Acting Beta-Agonists/Inhaled Corticosteroid
Prescribing of long-acting beta-2-agonists/inhaled corticosteroids after the SMART trial
RETRACTED ARTICLE: Inhaled corticosteroids and long-acting beta-agonists in adult asthma: a winning combination in all?
Long-acting beta-agonists plus inhaled corticosteroids safety: a systematic review and meta-analysis of non-randomized studies
Risk of active tuberculosis among COPD patients treated with fixed combinations of long-acting beta2 agonists and inhaled corticosteroids
Comparison of resource use by COPD patients on inhaled therapies with long-acting bronchodilators: a database study
Potential implications of long-acting GLP-1 receptor agonists for critically ill
Pharmacokinetic and pharmacodynamic characterization of inhaled β2-agonists [beta-2-agonists] using the isolated human lung perfusion model
The effect of combining an inhaled corticosteroid and a long-acting muscarinic antagonist on human airway epithelial cells in vitro
Tolerance to bronchodilation during treatment with long-acting beta-agonists, a randomised controlled trial
A comparison of tiotropium, long-acting β2-agonists and leukotriene receptor antagonists on lung function and exacerbations in paediatric patients with asthma
Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents
Add-on Therapy for Symptomatic Asthma despite Long-Acting Beta-Agonists/Inhaled Corticosteroid
Prescribing of long-acting beta-2-agonists/inhaled corticosteroids after the SMART trial
RETRACTED ARTICLE: Inhaled corticosteroids and long-acting beta-agonists in adult asthma: a winning combination in all?
Long-acting beta-agonists plus inhaled corticosteroids safety: a systematic review and meta-analysis of non-randomized studies
Risk of active tuberculosis among COPD patients treated with fixed combinations of long-acting beta2 agonists and inhaled corticosteroids
Comparison of resource use by COPD patients on inhaled therapies with long-acting bronchodilators: a database study
Potential implications of long-acting GLP-1 receptor agonists for critically ill
Pharmacokinetic and pharmacodynamic characterization of inhaled β2-agonists [beta-2-agonists] using the isolated human lung perfusion model
The effect of combining an inhaled corticosteroid and a long-acting muscarinic antagonist on human airway epithelial cells in vitro
Tolerance to bronchodilation during treatment with long-acting beta-agonists, a randomised controlled trial
A comparison of tiotropium, long-acting β2-agonists and leukotriene receptor antagonists on lung function and exacerbations in paediatric patients with asthma
Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents
Add-on Therapy for Symptomatic Asthma despite Long-Acting Beta-Agonists/Inhaled Corticosteroid
Prescribing of long-acting beta-2-agonists/inhaled corticosteroids after the SMART trial
RETRACTED ARTICLE: Inhaled corticosteroids and long-acting beta-agonists in adult asthma: a winning combination in all?
Long-acting beta-agonists plus inhaled corticosteroids safety: a systematic review and meta-analysis of non-randomized studies
Risk of active tuberculosis among COPD patients treated with fixed combinations of long-acting beta2 agonists and inhaled corticosteroids
Comparison of resource use by COPD patients on inhaled therapies with long-acting bronchodilators: a database study
Potential implications of long-acting GLP-1 receptor agonists for critically ill
Pharmacokinetic and pharmacodynamic characterization of inhaled β2-agonists [beta-2-agonists] using the isolated human lung perfusion model
The effect of combining an inhaled corticosteroid and a long-acting muscarinic antagonist on human airway epithelial cells in vitro
Tolerance to bronchodilation during treatment with long-acting beta-agonists, a randomised controlled trial
A comparison of tiotropium, long-acting β2-agonists and leukotriene receptor antagonists on lung function and exacerbations in paediatric patients with asthma